234 related articles for article (PubMed ID: 1832572)
1. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
2. [Platelet activation during exacerbation of bronchial asthma--thrombin induced ATP release from washed platelets and plasma beta-TG, PF4, beta-TG/PF4 ratio].
Yasuba H; Kino T; Fukuda K; Matsui Y; Izumi T; Oshima S; Chihara J
Arerugi; 1988 Dec; 37(12):1152-60. PubMed ID: 2977722
[No Abstract] [Full Text] [Related]
3. [The changes in plasma beta-thromboglobulin (beta-TG), platelet factor 4 (PF4) and thromboxane B2 (TXB2) after a bronchial provocation test (BPT) with house dust (HD) allergen].
Mizuno M; Adachi M; Maruyama S; Suganuma T; Okada T; Takahashi T
Arerugi; 1991 May; 40(5):500-5. PubMed ID: 1831967
[TBL] [Abstract][Full Text] [Related]
4. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
[TBL] [Abstract][Full Text] [Related]
5. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms.
Kasperska-Zajac A; Rogala B
Clin Exp Allergy; 2005 Nov; 35(11):1462-5. PubMed ID: 16297143
[TBL] [Abstract][Full Text] [Related]
6. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
7. Lack of increase or reduction in circulating platelet factor 4 and heparin-releasable platelet factor 4 in symptomatic patients with asthma.
Luzzatto G; Cella G; Boschetto P; Fabbri L
J Lipid Mediat; 1993 Jun; 7(2):151-4. PubMed ID: 8400116
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 release induced by intravenous administration of heparin.
Cella G; Scattolo N; Cappellato MG; Girolami A; Strauss WE; Sasahara AA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):165-74. PubMed ID: 2581862
[TBL] [Abstract][Full Text] [Related]
9. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
10. The evidence of platelet activation in bronchial asthma.
Yamamoto H; Nagata M; Tabe K; Kimura I; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):79-87. PubMed ID: 8423274
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus.
Kowal K; Pampuch A; Kowal-Bielecka O; DuBuske LM; Bodzenta-Łukaszyk A
Clin Exp Allergy; 2006 Apr; 36(4):426-32. PubMed ID: 16630146
[TBL] [Abstract][Full Text] [Related]
13. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on plasma platelet factor 4 in patients with bronchial asthma. Changes in bronchial inhalation tests by allergen and acetylcholine].
Toga H; Ohya N; Kitagawa S; Yoshida A
Arerugi; 1984 Aug; 33(8):474-9. PubMed ID: 6517718
[No Abstract] [Full Text] [Related]
15. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
16. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
18. Enhanced "in vitro" release of platelet alpha-granules after acute myocardial infarction (AMI).
Pengo V; Boschello M; Prandoni P; Schiavon R; Bellotto F; Schivazappa L; Dalla Volta S
Thromb Haemost; 1985 Aug; 54(2):544-6. PubMed ID: 2934859
[TBL] [Abstract][Full Text] [Related]
19. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
